assa sages

ISSUE HIGHLIGHTS

WGO NEWS

wgo

wgo

wgo

TOP NEWS

In a reminder of AI's limits, ChatGPT fails gastro exam
MedPage Today
OpenAI's ChatGPTopens in a new tab or window failed to achieve a passing score on a self-assessment practice test from the American College of Gastroenterology, researchers reported. Using questions from the ACG's 2021 and 2022 multiple-choice practice assessments, the GPT-3.5 and the GPT-4 versions scored a 65.1% and a 62.4%, respectively, according to Arvind Trindade, MD, of Northwell Health's Feinstein Institutes for Medical Research in Manhasset, New York, and co-authors. Read More

New FDA approvals increase variety in field of adalimumab biosimilars
Gastroenterology & Endoscopy News
New FDA approvals of adalimumab biosimilars are bringing more choice to prescribers, with high-dose concentrations and auto-injector formulations soon to be available. This week, the FDA approved adalimumab-aaty, a high-concentration and citrate-free biosimilar of Humira, as well as a new autoinjector option, adalimumab-adbm, an interchangeable biosimilar of adalimumab. Read More

Advertisement
HCL

New resource for gastroenterologists on using probiotics and prebiotics in clinical practice
International Scientific Association for Probiotics and Prebiotics via Medical Xpress
The World Gastroenterology Organization recently published an updated guideline document, aimed at helping gastroenterologists and other physicians understand appropriate clinical applications for probiotics or prebiotics. Read More

Risankizumab data back use in moderate to severe Crohn's disease
International Scientific Association for Probiotics and Prebiotics via Medical Xpress
Risankizumab has been shown to be well tolerated and superior to placebo for inducing and maintaining clinical remission and endoscopic response in people with moderate to severe Crohn's disease, noted Ryan Ungaro, M.D., an associate professor of medicine at the Icahn School of Medicine at Mount Sinai, in New York City. Read More

Prior authorization for colonoscopy will put patients at risk, says ACG's Dayna Early
MedPage Today
Announced this spring, UnitedHealthcare at the same time as announcing that they were going to reduce the burden of prior authorization in general stated that they were going to have a new policy starting June 1, that nearly all endoscopy procedures would require prior authorization before they would be willing to cover them. Read More

Cell-free DNA blood test 'poised to have significant impact' on CRC screening
Healio Gastroenterology
A cell-free DNA blood-based test displayed 83% sensitivity for colorectal cancer detection and 90% specificity in an average-risk population, similar to the performance of current noninvasive screening options. Read More

IBATs improve liver symptoms in PFIC and Alagille syndrome
Gastroenterology & Endoscopy News
The ileal bile acid transporter inhibitors odevixibat and maralixibat resulted in improvements in liver disease markers and symptoms and were well tolerated overall during several pediatric trials presented at The Liver Meeting 2022. The following is a summary of several studies. Read More

How BMI over time impacts GI cancer risk
Medscape
Higher body mass index and changes in BMI over time may increase a person's risk for gastrointestinal cancer, according to new data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Read More

EVENTS CALENDAR

BSG Live 2023
When: June 19-22, 2023
Location: Liverpool, United Kingdom
Organizer(s):British Society of Gastroenterology
Learn More

2023 International Liver Congress
When: June 21-25, 2023
Location: Vienna, Austria
Organizer(s): EASL
Learn More

GUT 2023
When: August 18-20, 2023
Location: Kuala Lumpur, Malaysia
Organizer(s): Malaysian Society of Gastroenterology & Hepatology
Learn More